Asia Deal Watch: Takeda On A Deal Spree

 
• By Ian Haydock, Jung Won Shin, and Joseph Haas

Takeda has inked three deals in recent days: a cancer antibody-drug conjugate partnership, a PI3K out-license and a nanomedicine drug-delivery pact. AstraZeneca gains expanded rights to Kyowa Hakko Kirin’s Fasenra.

KONSKIE, POLAND - JULY 21, 2018: Takeda Pharmaceutical company website displayed on a modern smartphone
Takeda Active in Deal-Making • Source: Shutterstock

More from Focus On Asia

More from Scrip